References
- Abe M, Hamada J, Takahashi O, Takahashi Y, Tada M, Miyamoto M, Morikawa T, Kondo S, Moriuchi T. Disordered expression of HOX genes in human non-small cell lung cancer. Oncology Reports. 2006. 15: 797-802.
- Allison KH. Molecular pathology of breast cancer: what a pathologist needs to know. Journal Of Clinical Pathology. 2012. 138: 770-780. https://doi.org/10.1309/AJCPIV9IQ1MRQMOO
- Cillo C, Barba P, Freschi G, Bucciarelli G, Magli MC, Boncinelli E. HOX gene expression in normal and neoplastic human kidney. International Journal of Cancer. 1992. 51: 892-897. https://doi.org/10.1002/ijc.2910510610
- Coussens LM, Zitvogel L, Palucka AK. Neutralizing tumorpromoting chronic inflammation: a magic bullet? Science. 2013. 339: 286-291. https://doi.org/10.1126/science.1232227
- Fessner A, Esser JS, Bluhm F, Grundmann S, Zhou Q, Patterson C, Bode C, Moser M. The transcription factor HoxB5 stimulates vascular remodelling in a cytokine-dependent manner. Cardiovascular Research. 2014. 101: 247-255. https://doi.org/10.1093/cvr/cvt244
- Gehring WJ, Hiromi Y. Homeotic genes and the homeobox. Annual Review of Genetics. 1986. 20: 147-173. https://doi.org/10.1146/annurev.ge.20.120186.001051
- Hong CS, Jeong O, Piao Z, Guo C, Jung MR, Choi C, Park YK. HOXB5 induces invasion and migration through direct transcriptional up-regulation of beta-catenin in human gastric carcinoma. Biochemical Journal. 2015. 472: 393-403. https://doi.org/10.1042/BJ20150213
- Hur H, Lee JY, Yun HJ, Park BW, Kim MH. Analysis of HOX gene expression patterns in human breast cancer. Molecular Biotechnology. 2014. 56: 64-71. https://doi.org/10.1007/s12033-013-9682-4
- Kam MK, Cheung MC, Zhu JJ, Cheng WW, Sat EW, Tam PK, Lui VC. Perturbation of Hoxb5 signaling in vagal and trunk neural crest cells causes apoptosis and neurocristopathies in mice. Cell Death & Differentiation. 2014. 21: 278-289. https://doi.org/10.1038/cdd.2013.142
- Lee JY, Hur H, Yun HJ, Kim Y, Yang S, Kim SI, Kim MH. HOXB5 promotes the proliferation and invasion of breast cancer cells. International Journal of Biological Sciences. 2015. 11: 701-711. https://doi.org/10.7150/ijbs.11431
- Li H, Huang CJ, Choo KB. Expression of homeobox genes in cervical cancer. Gynecologic Oncology. 2002. 84: 216-221. https://doi.org/10.1006/gyno.2001.6498
- Lin S, Gan Z, Han K, Yao Y, Min D. Interleukin-6 as a prognostic marker for breast cancer: a meta-analysis. Tumori Journal. 2015. 101: 535-541. https://doi.org/10.5301/tj.5000357
- Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008. 454: 436-444. https://doi.org/10.1038/nature07205
- Shah N, Jin K, Cruz LA, Park S, Sadik H, Cho S, Goswami CP, Nakshatri H, Gupta R, Chang HY, Zhang Z, Cimino-Mathews A, Cope L, Umbricht C, Sukumar S. HOXB13 mediates tamoxifen resistance and invasiveness in human breast cancer by suppressing ERalpha and inducing IL-6 expression. Cancer Research. 2013. 73: 5449-5458. https://doi.org/10.1158/0008-5472.CAN-13-1178
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA: A Cancer Journal for Clinicians. 2016. 66: 7-30. https://doi.org/10.3322/caac.21332
- Spitz F, Furlong EE. Transcription factors: from enhancer binding to developmental control. Nature Reviews Genetics. 2012. 13:613-626. https://doi.org/10.1038/nrg3207
- Sullivan NJ, Sasser AK, Axel AE, Vesuna F, Raman V, Ramirez N, Oberyszyn TM, Hall BM. Interleukin-6 induces an epithelialmesenchymal transition phenotype in human breast cancer cells. Oncogene. 2009. 28: 2940-2947. https://doi.org/10.1038/onc.2009.180
- Sun KY, Peng T, Chen Z, Huang J, Zhou XH. MicroRNA-1275 suppresses cell growth, and retards G1/S transition in human nasopharyngeal carcinoma by down-regulation of HOXB5. Journal of Cell Communication and Signaling. 2016. 10: 305-314. https://doi.org/10.1007/s12079-016-0351-9
- Wang KC, Helms JA, Chang HY. Regeneration, repair and remembering identity: the three Rs of Hox gene expression. Trends in Cell Biology. 2009. 19: 268-275. https://doi.org/10.1016/j.tcb.2009.03.007
- Zhang B, Li N, Zhang H. Knockdown of Homeobox B5 (HOXB5) inhibits cell proliferation, migration, and invasion in non-small cell lung cancer cells through inactivation of the Wnt/betacatenin pathway. Oncology Research. 2017. 7: 81527-81540.
- Zhu J, Garcia-Barcelo MM, Tam PK, Lui VC. HOXB5 cooperates with NKX2-1 in the transcription of human RET. PLoS One. 2011. 6: e20815. https://doi.org/10.1371/journal.pone.0020815